Range Cancer Therapeutics ETF (CNCR)

NASDAQ: CNCR · IEX Real-Time Price · USD
13.88
-0.39 (-2.73%)
At close: Jun 17, 2024, 12:00 AM
14.13
+0.25 (1.80%)
After-hours: Jun 17, 2024, 5:09 PM EDT
-2.73%
Assets $16.16M
Expense Ratio 0.79%
PE Ratio n/a
Shares Out 1.13M
Dividend (ttm) n/a
Dividend Yield n/a
Ex-Dividend Date n/a
Payout Ratio n/a
1-Year Return +1.68%
Volume 6,576
Open 14.09
Previous Close 14.27
Day's Range 13.88 - 14.27
52-Week Low 9.22
52-Week High 17.96
Beta 1.38
Holdings 78
Inception Date Oct 13, 2015

About CNCR

The Range Cancer Therapeutics ETF (CNCR) is an exchange-traded fund that is based on the Range Oncology Therapeutics index. The fund tracks an equal-weighted index of companies currently developing oncology drugs or selling cancer therapeutic products. CNCR was launched on Oct 13, 2015 and is issued by Range.

Asset Class Equity
Category Health
Stock Exchange NASDAQ
Ticker Symbol CNCR
ETF Provider Range
Index Tracked Range Oncology Therapeutics Index

Top 10 Holdings

22.95% of assets
Name Symbol Weight
Geron Corporation GERN 3.92%
Enliven Therapeutics, Inc. ELVN 2.68%
Summit Therapeutics Inc. SMMT 2.39%
US DOLLARS n/a 2.26%
Acrivon Therapeutics, Inc. ACRV 2.14%
iTeos Therapeutics, Inc. ITOS 2.13%
Nuvation Bio Inc. NUVB 1.92%
Agenus Inc. AGEN 1.87%
Merus N.V. MRUS 1.82%
Cullinan Oncology, Inc. CGEM 1.81%
View More Holdings

News

Last Week in ETFs: 8 New Defined Outcome ETFs Debut

Last week was a busy one for ETFs, with nine new ETFs launching on the first day of the week alone. Calamos, Innovator, AllianzIM, Direxion, Global X and ProShares were among the issuers rolling out n...

7 days ago - ETF Trends

EXCHANGE TRADED CONCEPTS, LLC., ANNOUNCES COMPLETION OF FUND REORGANIZATION

OKLAHOMA CITY , Oct. 23, 2023 /PRNewswire/ -- Exchange Traded Concepts, LLC, adviser to the Range Cancer Therapeutics ETF (CNCR) and the Loncar China BioPharma ETF (CHNA) is pleased to announce the co...

8 months ago - PRNewsWire

Should Investors Follow Private Equity into Life Sciences?

Reflecting what it considers the vast potential of life sciences companies, Bain Capital is making another huge bet on the industry. The Boston-based investment firm has raised $1.9 billion in a new f...

Other symbols: BBCBNTXCEREPFE
3 years ago - GuruFocus

9 Best Biotech ETFs to Play High-Octane Trends

Biotechnology is a dynamic but often volatile industry. These biotech ETFs provide a lower-risk way to invest in the space.

3 years ago - Kiplinger

Biotech ETFs extend January gains

Biotech exchange-traded funds rallied Monday as investors continued to monitor the sector and its impact on the coronavirus pandemic. The ETFMG Treatments Testing and Advancement ETF gained 4.6% mid-m...

Other symbols: GERMXBI
3 years ago - Market Watch

Specialty biotech funds jump on promising coronavirus, funding news

Specialized health-care exchange-traded funds outperformed the broader stock market Wednesday even as stocks rebounded from a sell-off that left the Nasdaq Composite Index in correction territory. Th...

Other symbols: PTH
4 years ago - Market Watch

6 Best Biotech ETFs to Buy for Cutting-Edge Growth

Biotech ETFs are, in a word, hot.

Other symbols: BTECGERMIBBPBEXBI
4 years ago - Kiplinger

3 ETFs For More Moderna Bets

Shares of biotechnology company Moderna Inc (NASDAQ: MRNA) jumped 20% Monday on news that its mRNA-1273 coronavirus vaccine candidate is making positive progress.

Other symbols: BTECIDNA
4 years ago - Benzinga